Carmell Therapeutics Corporation Stock Forecast
Volatile ride for Carmell Therapeutics Corporation stock price on Tuesday moving between $1.24 and $1.48
(Updated on Jun 25, 2024)
The Carmell Therapeutics Corporation stock price fell by -11.35% on the last day (Tuesday, 25th Jun 2024) from $1.41 to $1.25. During the last trading day the stock fluctuated 19.35% from a day low at $1.24 to a day high of $1.48. The price has fallen in 9 of the last 10 days and is down by -50% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -238 shares and in total, 8 thousand shares were bought and sold for approximately $9.66 thousand.
The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($1.57) are considered to be a "second chance" to get out. According to the fan-theory $0.617 will represent the new bottom line of the next trend, but it is far too early to say this for certain.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CTCX Signals & Forecast
There are few to no technical positive signals at the moment. The Carmell Therapeutics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.60 and $2.19. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 05, 2024, and so far it has fallen -52.83%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Carmell Therapeutics Corporation stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.240 between high and low, or 19.35%. For the last week the stock has had daily average volatility of 15.03%.
Carmell Therapeutics Corporation is oversold on RSI14 (4). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CTCX) For The Upcoming Trading Day Of Wednesday 26th
For the upcoming trading day on Wednesday, 26th we expect Carmell Therapeutics Corporation to open at $1.32, and during the day (based on 14 day Average True Range), to move between $1.02 and $1.48, which gives a possible trading interval of +/-$0.228 (+/-18.22%) up or down from last closing price. If Carmell Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 36.44% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $1.41, some $0.160 (12.80%) from the current price of $1.25, our system finds the risk reward not very attractive.
Earnings coming up
Carmell Therapeutics Corporation will release earnings BMO on Monday, July 01, 2024. We will update the financials statements for Carmell Therapeutics Corporation, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.26% in the first trading day after earnings release.
Is Carmell Therapeutics Corporation stock A Buy?
Carmell Therapeutics Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -6.875 Strong Sell Candidate Unchanged
Predicted Opening Price for Carmell Therapeutics Corporation of Wednesday, June 26, 2024
Fair opening price June 26, 2024 | Current price |
---|---|
$1.32 ( 5.87%) | $1.25 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CTCX
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 1.56 | 25.06% |
R2 | 1.47 | 17.73% |
R1 | 1.42 | 13.20% |
Price | 1.25 | |
S1 | 1.23 | -1.46% |
S2 | 1.18 | -5.99% |
S3 | 1.08 | -13.32% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 1.53 | 22.40% |
R2 | 1.52 | 21.60% |
R1 | 1.41 | 12.80% |
Price | 1.25 | |
S1 | 0 | - |
S2 | 0 | - |
S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Carmell Therapeutics Corporation Stock.